JEPrifa
Description_Effects
JEPrifa contains Rifaximin, a non-absorbable antibiotic used primarily to treat traveler’s diarrhea caused by the bacteria Escherichia coli (E. coli). Traveler’s diarrhea is a common condition experienced by people traveling to regions with lower hygiene standards, and it typically causes symptoms like loose stools, abdominal cramps, nausea, and urgency to defecate. JEPrifa works by inhibiting bacterial RNA synthesis, thereby killing or stopping the growth of E. coli in the intestines. Since Rifaximin is minimally absorbed into the bloodstream, its action is localized in the gut, which helps reduce systemic side effects and makes it safer for targeted treatment. This medicine is effective in relieving symptoms quickly and is generally well tolerated. It is typically taken for a short duration (usually 3 days), and patients often notice improvement within the first 24 to 48 hours. However, it should only be used if the diarrhea is not associated with fever or blood in the stool, as those symptoms may suggest a more severe infection that requires different treatment. JEPrifa may also be used under medical guidance for other conditions such as hepatic encephalopathy or small intestinal bacterial overgrowth (SIBO). For best results, it should be taken exactly as prescribed by a healthcare professional.
